Oticon Zeal Receives Red Dot Design Award
The award highlights the discreet hearing aid's design, innovation, and user-centered features.
The award highlights the discreet hearing aid's design, innovation, and user-centered features.
In a pivotal trial, 42% of participants achieved normal hearing using the gene therapy indicated for pediatric and adult patients with severe-to-profound hearing loss due to biallelic OTOF gene variants.
New over-the-counter hearing aids and smart glasses with advanced audio features were showcased by multiple companies at CES 2026 in Las Vegas.
The partnership aims to explore the integration of novel drug-delivery methods with future cochlear implant technology.
Priorities include the Stop CMV Act, Ally’s Act, and Medicare physician reimbursement reform.
Findings from the state's mandated program demonstrate a decreased age at first audiology visit and increased detection of mild hearing loss in infants.
The former Cochlear executive brings extensive digital health experience to the hearing care practice management software company.
The 8th International Conference on Hyperacusis and Misophonia will be held as part of the EUHA Congress in October 2026, with a call for abstracts now open.
Oticon will present its newest hearing technology at the upcoming audiology conference.